Latest Health News
Resurgence of Measles in the United States
CSIS hosts a live event on March 12, 2026, addressing the measles resurgence via the Bipartisan Alliance for Global Health Security. This follows alerts in regions like Western Australia with 4 cases year-to-date. Health professionals urge urgent notifications and MMR vaccinations for travelers.
Protein Rip1 Discovered as Anti-Bacterial Defense Mechanism
University of Toronto and Caltech researchers identified Rip1 protein that detects phage proteins, forms pores in bacterial membranes, and kills cells before viral replication. This targets antibiotic-resistant bacteria using synthetic molecules. It offers a new therapy class hard for bacteria to resist.
Bacteria Survive Asteroid Impact Simulations Supporting Panspermia
Johns Hopkins study on March 3, 2026, used a gas gun to simulate 3 GPa pressures on Deinococcus radiodurans; 60% survived at 2.4 GPa with rapid DNA repair activation. This bolsters lithopanspermia theory of interplanetary life transfer. Findings published in PNAS Nexus.
ICN Expresses Solidarity with Middle East Nurses Amid Violence
On March 5, 2026, International Council of Nurses voiced deep solidarity with nurses and health workers facing escalating violence in the Middle East and Gulf. WHPA calls for global action against rising persecution of health professionals post-COVID.
Western Australia Issues Measles Alert with 4 Cases in 2026
WA Health reports 4 measles cases year-to-date as of March 6, 2026, with exposure sites listed including ARB Wangara and St John of God Geraldton Hospital. Incubation is about 10 days; urgent notification to public health units required. Free MMR vaccines available for susceptibles.
RSV Leads Respiratory Virus Positivity in Canada Week 8
Canada's FluWatch+ reports highest RSV positivity at 8.4% (2,359 detections) for week ending February 28, 2026, surpassing COVID-19 and influenza. Pediatric hospitalizations tracked via SPRINT-KIDS show ongoing severe outcomes. Data includes lab-confirmed detections and rates by age.
Nicoya Lifesciences Launches FastHDX for Protein Analysis
On March 5, 2026, Nicoya announced FastHDX™, a millisecond HDX-MS platform boosting labeling resolution by 4-5 orders for transient protein insights and new therapeutics. It aims to unlock opportunities in drug development.
Venetoclax Off-Switch Developed for Split CAR Therapies
March 3, 2026 study describes a pharmacologic off-switch for CAR systems using venetoclax for dose-dependent control in vitro and in vivo. This enhances safety in cancer immunotherapies. Published in relevant pharma journals.
Robotic Caudate Lobe Resection Advances Liver Cancer Surgery
Boston University researchers demonstrate safe robotic removal of caudate lobe in older patients using Arantius ligament traction and ICG staining for precise margins. Published in Annals of Surgical Oncology. This targets hard-to-reach liver cancers.
PTP1B Protein Identified as Immunogenic Cell Death Switch in Cancer
NUS team found PTP1B modulates immunogenic cell death (ICD) in cancer cells; platinum compounds Pt-NHC and Pt-ER trigger ICD. Preclinical methionine restriction also shows anti-tumor synergy with therapies. Implications for inflammatory diseases too.
Patient Cured of Treatment-Resistant Depression After 31 Years
A 44-year-old with 31 years of treatment-resistant depression finds joy via major scientific breakthrough as of March 6, 2026. Details highlight novel intervention success. This marks a significant mental health advance.
Total Artificial Heart Shows Promise for Heart Failure
Continuous-flow total artificial heart demonstrates early durable biventricular support potential, reshaping end-stage heart failure options. ACS Bulletin covers March 4, 2026 advancements. Faces defining chapter with real momentum.